| Literature DB >> 35567294 |
Kaliyaperumal Ashokkumar1, Jesus Simal-Gandara2, Muthusamy Murugan1, Mannananil Krishnankutty Dhanya1, Arjun Pandian3.
Abstract
Myristica fragrans (Houtt.) is an evergreen tree native to the Maluku Islands, Indonesia. M. fragrans kernel is extensively used in Indian traditional medicines to treat various diseases. Several studies attempt to compile and interpret the pharmacological potential of Myristica fragrans (Houtt.) aqueous and various chemical extracts. Thus, the pharmacological potential of nutmeg essential oil has not been reviewed phytochemically and pharmacologically. Therefore, the present study aimed to share appropriate literature evidence regarding the plant essential oil chemical composition and therapeutic potential of Myristica fragrans essential oil (MFEO). MFEO of leaf, mace, kernel, and seed were used worldwide as potential Ayurvedic medicine and fragrance. MFEO extracted by various methods and oil yield was 0.7-3.2, 8.1-10.3, 0.3-12.5, and 6.2-7.6% in leaf, mace, seed, and kernel. The primary chemical constituents of MFEO were sabinene, eugenol, myristicin, caryophyllene, β-myrcene, and α-pinene. Clinical and experimental investigations have confirmed the antioxidant, antimicrobial, antiinflammatory, anticancer, antimalarial, anticonvulsant, hepatoprotective, antiparasitic, insecticidal, and nematocidal activities of MFEO. It is the first attempt to compile oil yield, composition, and the biological activities of MFEO. In future, several scientific investigations are required to understand the mechanism of action of MFEO and their bioactive constituents.Entities:
Keywords: Myristica fragrans; biological activities; chemical composition; essential oil; myristicin; nutmeg; sabinene
Mesh:
Substances:
Year: 2022 PMID: 35567294 PMCID: PMC9541156 DOI: 10.1002/ptr.7491
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 6.388
FIGURE 1Morphological identification of Myristica fragrans Houtt. (a) The young tree; (b) leaves of the plant; (c) fruit; (d) seed; (e) rind; (f) kernel (nutmeg); (g) mace (aril); (h) ground powder of mace; and (i) mace essential oil
Yield of essential oil from various parts of Myristica fragrans
| Parts | Extraction method | Volatile oil (%) | References |
|---|---|---|---|
| Leaf | Hydrodistillation | 3.2 | Ashokkumar et al. ( |
| Leaf | Steam distillation | 0.7 | Carolina and Maman ( |
| Mace | Hydrodistillation | 8.1 | Ashokkumar et al. ( |
| Mace | Hydrodistillation | 10.3 | Muhammad et al. ( |
| Kernel | Hydrodistillation | 6.2 | Ashokkumar et al. ( |
| Kernel | Hydrodistillation | 7.6 | Muhammad et al. ( |
| Seed | Hydrodistillation | 5.2 | Ashokkumar et al. ( |
| Seed | Hydrodistillation | 5.1–7.2 | Waman ( |
| Seed | Hydrodistillation | 6.9 | Muchtaridi, Subarnas, Apriyantono, and Mustarichie ( |
| Seed | Hydrodistillation | 5.8 | Ibrahim, Cantrell, Jeliazkova, Astatkie, and Zheljazkov ( |
| Seed | Hydrodistillation | 7.1 | Nikolic et al. ( |
| Seed | Hydrodistillation | 8.4 | Mickus et al. ( |
| Seed | Steam distillation | 4.5–7.5 | Al‐Jumaily and Al‐Amiry ( |
| Seed | Steam distillation | 0.3 | Carolina and Maman ( |
| Seed | Steam distillation | 12.5 | Purseglove, Brown, Green, and Robbins ( |
| Seed | Microwave‐assisted hydrodistillation | 3.8–5.8 | Sagarika et al. ( |
| Kernel | CO2 supercritical fluid extraction | 5.9 | Hanif et al. ( |
Major constituents of Myristica fragrans essential oils from various geographical origins
| Geographical origins | Parts | Constituents | Reference |
|---|---|---|---|
| India (Western Ghats) | Leaf | Sabinene (17.2%), eugenol (16.6%), myristicin (9.1%), caryophyllene (8.8%), α‐pinene (5.4%), β‐pinene (6.4%), limonene (5.0%), β‐Myrcene (4.7%), copaene (3.2%), germacrene D (3.0%) | Ashokkumar et al. ( |
| India (Western Ghats) | Mace | Sabinene (38.4%), α‐pinene (8.2%), β‐pinene (7.6%), limonene (7.1%), myristicin (5.9%), 3‐carene (5.1%), 4‐carene (4.2%), safrole (3.9%), β‐phellandrene (3.6%), terpinen‐4‐ol (3.0%) | Ashokkumar et al. ( |
| Pakistan | Mace | γ‐Terpinene (19.1%), safrole (18.2%), terpinen‐4‐ol (12.7%), α‐pinene (11.6%), sabinene (11.2%), myristicin (7.5%) | Muhammad et al. ( |
| Sri Lanka | Kernel | Sabinene (43.4%), α‐pinene (17.5%), β‐pinene (12.1%), α‐phellandrene (4.3%), limonene (3.2%), terpinen‐4‐ol (3.5%), myristicin (3.0%) | Sarath‐Kumara, Jans, and Dharmadasa ( |
| India (Western Ghats) | Kernel | Sabinene (38.0%), α‐pinene (19.2%), β‐pinene (14.9%), limonene (7.2%), β‐myrcene (3.4%) | Ashokkumar et al. ( |
| India (Western Ghats) | Seed | Sabinene (27.7%), α‐pinene (21.8%), β‐pinene (18.2%), limonene (6.4%), β‐myrcene (2.9%) | Ashokkumar et al. ( |
| Indonesia (West Java) | Seed | Sabinene (21.4%), α‐pinene (10.2%), myristicin (10.6%), 4‐terpineol (13.9%), safrole (4.3%), γ‐terpinene (4.0%) | Muchtaridi et al. ( |
| India (Andaman & Nicobar Islands) | Seed | Myristicin (20.3%), sabinene (19.3%), α‐thujene (12.1%), α‐pinene (9.5%), 4‐terpineol (7.1%), limonene (5.9%), γ‐terpinene (4.1%), elemicin (4.0%) | Waman ( |
| Pakistan | Seed | Sabinene (18.9%), α‐pinene (15.8%), cymene (15.2%), terpinen‐4‐ol (11.7%), elemicin (11.5%), safrole (6.2%) | Muhammad et al. ( |
| Brazil | Seed | β‐Pinene (12.4–26.0%), sabinene (9.1–25.0%), α‐pinene (10.5–14.1%), myristicin (10.9%), γ‐terpinene (8.5%), limonene (6.3%), terpinen‐4‐ol (3.5%) | Valente, Jham, Dhingra, and Ghiviriga ( |
| Grenada | Seed | Sabinene (52.8%), α‐pinene (13.5%), α‐terpinyl acetate (6.0%), limonene (7.0%), γ‐terpinene (4.1%), β‐pinene (3.6%), | Mickus et al. ( |
FIGURE 2Some major compounds of Myristica fragrans Houtt. essential oils
Biological activities of Myristica fragrans essential oil and its bioactive components
| Biological activities | MFEO/active constituent | In vitro/in vivo | Target/ model | Control(s) | IC50/dosage | Results/remarks | Reference |
|---|---|---|---|---|---|---|---|
| Antioxidant activity | MFEO | In vitro | DPPH assay | Negative: Ethanol | EC50: 1.35 mg/ml | Good antioxidant activity observed after 20 min incubation | Nikolic et al. ( |
| Antioxidant activity |
Elemicin 4‐terpineol Myristicin | In vitro | DPPH (Trolox equivalents) assay | Negative: Methanol |
IC50:11.78 μM/g IC50:1.48 μM/g IC50:3.24 μM/g | The most potential antioxidant compound in the DPPH test was elemicin | Adiani, Gupta, Chatterjee, Variyar, and Sharma ( |
| Antioxidant activity | MFEO | In vitro | DPPH assay | Negative: Ethanol | 0.2–20% concentration | Antioxidant activity was increased in a dose‐dependent manner. | Matulyte et al. ( |
| Antibacterial activity | MFEO | In vitro |
| Negative: DMSO | MIC: 0.2–1.0% | The concentration 0.2%, 0.5%, and 1% effectively suppress the growth of | Matulyte et al. ( |
| Antibacterial activity | MFEO | In vitro |
| Positive: Gentamicin | MIC: 2.5% | MFEO have 10.89 mm inhibitory effects at 2.5% | Ansory, Fitriani, and Nilawati. ( |
| Antibacterial activity | MFEO | In vitro |
| Negative: DMSO |
MIC: 83.3 μg/ml MIC: 79.2 μg/ml MIC: 88.1 μg/ml | The inhibition zone was 8.1, 9.0, and 8.2 mm, with the best inhibitory effect against | Purkait et al. ( |
| Antimicrobial activity | MFEO | In vitro |
| – | MIC: 3.2 μg/ml −12.5 μg/ml | MFEO had displayed significant antimicrobial activity against all the microorganism. | Özkan et al. ( |
| Antibacterial activity | MFEO | In vitro |
| Negative: Sterile water |
MIC: 0.05% MBC: 0.1% | MFEO inhibited both Gram‐positive and Gram‐negative bacteria equally well | Cui et al. ( |
| Antifungal activity | MFEO | In vitro |
| Negative: Ethanol |
MIC: 0.1% MIC: 0.3% |
0.3% inhibited | Valente et al. ( |
| Antifungal activity | MFEO | In vitro |
| Negative: Sterile water |
MIC: 0.31–2.5 μg/ml MBC: 0.31–2.5 μg/ml | Inhibition zone ranged between 8.3 and 30 mm with anticandidal activity against all tested | Thileepan et al. ( |
| Antimicrobial activity | MFEO | In vitro |
| Positive: Nystatin | MIC: 0.1% | The inhibition zone was 28, 14, 14, 23, 14, and 15 mm with the best inhibitory effect against | Nikolic et al. ( |
| Antimalarial activity | MFEO | In vitro |
| – | MIC: 16 μg/ml | MFEO showed some antimicrobial activities | Ibrahim et al. ( |
| Fumigant activity | MFEO | In vivo |
| Negative: Untreated beans | LC50: 30 μl/L for 24 hr | 100% mortality of adults | Alibabaie and Safaralizadeh ( |
|
Larvicidal activity | MFEO | In vivo |
| Negative: Distilled water |
LC50: 110.1 μg/ml for 24 hr | Significant larvicidal activity was noticed | Carolina and Maman ( |
| Insecticidal activity | MFEO | In vivo |
| Negative: Hexane | LD50: 19.3 mg/adult for 24 hr | MFEO exhibited strong contact toxicity against | Shu‐Shan et al. ( |
| Insecticidal activity | Elemicin | In vivo |
| Negative: Hexane | LD50: 9.8 mg/adult for 24 hr | Elemicin showed strong contact toxicity against | Shu‐Shan et al. ( |
| Insecticidal activity | MFEO | In vivo |
| – | LC50: 2.2 μg/ml LC50: 8.6 μg/ml | Topical application of MFEO was toxic to | Cossetin et al. ( |
Note: Not reported; EC₅₀, Half maximal effective concentration; IC₅₀, Half maximal inhibitory concentration; MFEO, Myristica fragrans essential oil; LC50, Lethal concentration 50%; LD50, Lethal dose 50%; MIC, Minimum inhibition concentration; MBC, Minimum bactericide concentration.
Pharmacological activities of Myristica fragrans essential oil and its active components
| Biological activities | MFEO/active constituent | In vitro/in vivo | Target/model | Control(s) | IC, LD50/dosage | Results/remarks | Reference |
|---|---|---|---|---|---|---|---|
| Cytotoxic activity | MFEO | In vitro | Vero cell line | – | IC50: 24.8 μg/ml | Low cytotoxicity observed against Vero cell line | Piaru et al. ( |
| Anticancer activity | MFEO | In vitro | Human colon adenocarcinoma cell line (undifferentiated Caco‐2 cells) | Positive: Myristicin | IC50: 250 μg/ml | MFEO were found to have a considerable inhibitory effect on the growth of a colon cancer cell line | Piras et al. ( |
| Antiinflammatory activity | MFEO | In vitro | hTERT‐immortalized foreskin fibroblast cell line, BJ‐5ta treated with viral dsRNR mimetic poly I:C |
Negative: 96% ethanol | LD50: 1 mg/ml | Nutmeg essential oils and hydrolats have shown significant antiinflammatory effect protecting cell viability | Matulyte et al. ( |
| Hepatoprotective activity | MFEO | In vivo | Male albino mice | – | 500, 1,000, mg/kg for 24 hr | MFEO‐treated mice showed substantial alteration in the biochemical indicators of liver function in a dose‐dependent manner | Al‐Jumaily & Al‐Amiry, |
| Antiinflammatory activity | MFEO | In vivo | Complete Freund's adjuvant (CFA)‐injected rats (30 mg/kg/day) | Positive: Diclofenac | 20 mg/kg/day | MFEO potentially alleviated the CFA injection‐induced joint swelling, mechanical allodynia of rats through inhibition of COX‐2 expression, and blood substance P level | Zhang et al. ( |
| Anticonvulsant activity | MFEO | In vivo | Male mice | Positive: Valproic acid | LD50:2150 μL/kg for 24 hr | Substantial anticonvulsant activity was observed | Wahab, Ul Haq, Ahmed, Khan, and Raza ( |
| Anticonvulsant activity | α‐Terpineol | In vivo | Genetic absence epilepsy rats from Strasbourg (GAERS) rats | Positive: Diazepam | 10, 20, 50 mg/kg, i.p. | Intraperitoneal dose 10 mg/kg was less effective to control seizures and spike and wave discharges (SWDs) in GAERS rats, but 20 mg/ kg and 50 mg/kg (i.p.) decreased the number of seizure episodes and number of SWDs | Islam et al. ( |
Note: Not reported; IC50, inhibitory concentration, LD50, lethal concentration; MFEO, Myristica fragrans essential oil.
FIGURE 3Diagrammatic representation of potential biological and pharmacological activities of M. fragrans essential oil